author-photo

Daniel H. Ryan

University of Rochester
University of Rochester Medical Center

136

Papers

4363

Citations

Citation Trend

Filter By

Papers (95) Sort By

Journal Conference Others

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (4)
56 Ageism in Myelodysplastic Syndrome

2021 Age and Ageing
Show All
- Source
- Cite
- Save
Citations (0)
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (5)
An integrated multidisciplinary model of COVID-19 recovery care.

2020 Irish Journal of Medical Science
Show All
- Source
- Cite
- Save
Citations (13)
Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
230 The Impact of a Palliative Care ECHO Programme on Symptom Severity Scores and Phases Score in a Nursing Home Population

2019 Age and Ageing
Show All
- Source
- Cite
- Save
Citations (0)
Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group

2019 Irish Journal of Medical Science
Show All
- Source
- Cite
- Save
Citations (15)
219 The Effect of Introducing In-house Radiographers Out of Hours on Door to CT Times for FAST Positive Patients

2019 Age and Ageing
Show All
- Source
- Cite
- Save
Citations (0)
OUTCOMES WITH CPX-351 VERSUS 7+3 BY BASELINE BONE MARROW BLAST PERCENTAGE IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK/SECONDARY AML: EXPLORATORY ANALYSIS OF A PHASE 3 STUDY: PB1733

2019
Show All
- Source
- Cite
- Save
Citations (0)